Clinical Trial: IH, Brain Health, and T2D

U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07173543) titled 'IH, Brain Health, and T2D' on Sept. 02.

Brief Summary: The purpose of this study is to use a randomized, placebo-controlled study design to rigorously examine the therapeutic potential of intermittent hypoxia (IH) for improving cerebrovascular health in older adults with and without type 2 diabetes mellitus (T2DM).

Study Start Date: Sept. 22

Study Type: INTERVENTIONAL

Condition: Type 2 Diabetes Aging

Intervention: OTHER: Intermittent Hypoxia 1 (IH1)

Intermittent Hypoxia 1 (IH1): 5 cycles of normoxia (4 minutes)/hypoxia (6 minutes) per session. 3 sessions per week for 8 weeks

OTHER: Intermittent Hypoxia 2 (IH2)

Intermittent...